High-Priority Research in Tobacco Regulatory Science
National Institutes of Health (NIH)
Total funding amount: Up to $4 million
Maximum budget per application: $500,000 in direct costs per year
Maximum project period: 5 years
To support high-priority biomedical and behavioral research that informs the regulation of tobacco products to protect public health.
U.S. Food and Drug Administration (FDA)
Public health community
Researchers in tobacco regulatory science
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local governments, state governments, and tribal governments.
Nonprofits must have 501(c)(3) status or not.
Foreign organizations and non-domestic entities are eligible to apply.
Open to U.S. and foreign organizations.
Research must address high-priority topics related to FDA's regulatory authority over tobacco products.
Projects must propose high-priority research aims within the regulatory authority of FDA CTP.
No cost sharing is required.
Application budgets are limited to $500,000 in direct costs per year.
Application opening date: May 6, 2025
Application deadline: June 6, 2025
Applicants may submit more than one application, provided each is scientifically distinct.
The NIH will not accept duplicate or highly overlapping applications.
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated based on significance, innovation, rigor, feasibility, and expertise.
Applications will undergo peer review and be evaluated for scientific and technical merit.
Scientific and technical merit of the proposed project will be a key factor in funding decisions.
Encouragement to incorporate measures from the PhenX Toolkit for data harmonization.
Applicants must ensure compliance with all application instructions to avoid delays or rejection.
Research should align with FDA's regulatory priorities.
Applications that address high-priority research topics are more likely to be funded.
Clear alignment with FDA regulatory priorities and high-priority research topics.
Submitting overlapping applications or failing to comply with application instructions.
Engage with NIH contacts for guidance on application responsiveness.
Highlight unique aspects of the proposed research that align with public health goals.